The cost of screening for synchronous thyroid disease in patients presenting with primary hyperparathyroidism

Christopher S. Hollenbeak, Irina Lendel, Kirt S. Beus, James M. Ruda, Brendan C. Stack

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Objective: To use decision analysis to compare the costs associated with minimally invasive parathyroidectomy (MIP) and bilateral neck exploration (BNE) in patients with primary hyperparathyroidism with regard to treatment of incidental synchronous thyroid disease. Design: We developed a decision tree model to evaluate the cost of managing thyroid pathology in primary hyperparathyroidism with the following 3 approaches: MIP, MIP with preoperative ultrasonography, and routine BNE with intraoperative thyroid evaluation. We tested the robustness of the optimal decision with sensitivity analyses. Setting: A tertiary care academic medical center. Main Outcome Measure: Total costs from a provider perspective. Results: Minimally invasive parathyroidectomy without an active search for thyroid abnormalities was determined to have the lowest expected cost ($5275 per patient). Parathyroid surgery with routine preoperative thyroid ultrasonography and further thyroid treatment as indicated had an expected cost of $5910 per patient. Bilateral neck exploration with intraoperative thyroid evaluation and treatment of the thyroid gland had an expected cost of $5916 per patient. Sensitivity analyses confirmed the robustness of the results across a reasonable range of surgical and imaging costs. Conclusions: Minimally invasive parathyroidectomy is not contraindicated on the basis of cost by an inability to screen for synchronous thyroid disease. In addition, ultrasonographic screening of the thyroid glands of patients undergoing MIP is not cost prohibitive and, in fact, is less costly than BNE. Ultrasonography has the added advantage of confirming the location of the offending parathyroid.

Original languageEnglish (US)
Pages (from-to)1013-1021
Number of pages9
JournalArchives of Otolaryngology - Head and Neck Surgery
Volume133
Issue number10
DOIs
StatePublished - Oct 1 2007

Fingerprint

Primary Hyperparathyroidism
Thyroid Diseases
Parathyroidectomy
Thyroid Gland
Costs and Cost Analysis
Neck
Ultrasonography
Decision Trees
Decision Support Techniques
Tertiary Healthcare
Therapeutics
Outcome Assessment (Health Care)
Pathology

All Science Journal Classification (ASJC) codes

  • Otorhinolaryngology

Cite this

@article{ab629b47f84f4a6fbec981966f7164e7,
title = "The cost of screening for synchronous thyroid disease in patients presenting with primary hyperparathyroidism",
abstract = "Objective: To use decision analysis to compare the costs associated with minimally invasive parathyroidectomy (MIP) and bilateral neck exploration (BNE) in patients with primary hyperparathyroidism with regard to treatment of incidental synchronous thyroid disease. Design: We developed a decision tree model to evaluate the cost of managing thyroid pathology in primary hyperparathyroidism with the following 3 approaches: MIP, MIP with preoperative ultrasonography, and routine BNE with intraoperative thyroid evaluation. We tested the robustness of the optimal decision with sensitivity analyses. Setting: A tertiary care academic medical center. Main Outcome Measure: Total costs from a provider perspective. Results: Minimally invasive parathyroidectomy without an active search for thyroid abnormalities was determined to have the lowest expected cost ($5275 per patient). Parathyroid surgery with routine preoperative thyroid ultrasonography and further thyroid treatment as indicated had an expected cost of $5910 per patient. Bilateral neck exploration with intraoperative thyroid evaluation and treatment of the thyroid gland had an expected cost of $5916 per patient. Sensitivity analyses confirmed the robustness of the results across a reasonable range of surgical and imaging costs. Conclusions: Minimally invasive parathyroidectomy is not contraindicated on the basis of cost by an inability to screen for synchronous thyroid disease. In addition, ultrasonographic screening of the thyroid glands of patients undergoing MIP is not cost prohibitive and, in fact, is less costly than BNE. Ultrasonography has the added advantage of confirming the location of the offending parathyroid.",
author = "Hollenbeak, {Christopher S.} and Irina Lendel and Beus, {Kirt S.} and Ruda, {James M.} and Stack, {Brendan C.}",
year = "2007",
month = "10",
day = "1",
doi = "10.1001/archotol.133.10.1013",
language = "English (US)",
volume = "133",
pages = "1013--1021",
journal = "JAMA Otolaryngology - Head and Neck Surgery",
issn = "2168-6181",
publisher = "American Medical Association",
number = "10",

}

The cost of screening for synchronous thyroid disease in patients presenting with primary hyperparathyroidism. / Hollenbeak, Christopher S.; Lendel, Irina; Beus, Kirt S.; Ruda, James M.; Stack, Brendan C.

In: Archives of Otolaryngology - Head and Neck Surgery, Vol. 133, No. 10, 01.10.2007, p. 1013-1021.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The cost of screening for synchronous thyroid disease in patients presenting with primary hyperparathyroidism

AU - Hollenbeak, Christopher S.

AU - Lendel, Irina

AU - Beus, Kirt S.

AU - Ruda, James M.

AU - Stack, Brendan C.

PY - 2007/10/1

Y1 - 2007/10/1

N2 - Objective: To use decision analysis to compare the costs associated with minimally invasive parathyroidectomy (MIP) and bilateral neck exploration (BNE) in patients with primary hyperparathyroidism with regard to treatment of incidental synchronous thyroid disease. Design: We developed a decision tree model to evaluate the cost of managing thyroid pathology in primary hyperparathyroidism with the following 3 approaches: MIP, MIP with preoperative ultrasonography, and routine BNE with intraoperative thyroid evaluation. We tested the robustness of the optimal decision with sensitivity analyses. Setting: A tertiary care academic medical center. Main Outcome Measure: Total costs from a provider perspective. Results: Minimally invasive parathyroidectomy without an active search for thyroid abnormalities was determined to have the lowest expected cost ($5275 per patient). Parathyroid surgery with routine preoperative thyroid ultrasonography and further thyroid treatment as indicated had an expected cost of $5910 per patient. Bilateral neck exploration with intraoperative thyroid evaluation and treatment of the thyroid gland had an expected cost of $5916 per patient. Sensitivity analyses confirmed the robustness of the results across a reasonable range of surgical and imaging costs. Conclusions: Minimally invasive parathyroidectomy is not contraindicated on the basis of cost by an inability to screen for synchronous thyroid disease. In addition, ultrasonographic screening of the thyroid glands of patients undergoing MIP is not cost prohibitive and, in fact, is less costly than BNE. Ultrasonography has the added advantage of confirming the location of the offending parathyroid.

AB - Objective: To use decision analysis to compare the costs associated with minimally invasive parathyroidectomy (MIP) and bilateral neck exploration (BNE) in patients with primary hyperparathyroidism with regard to treatment of incidental synchronous thyroid disease. Design: We developed a decision tree model to evaluate the cost of managing thyroid pathology in primary hyperparathyroidism with the following 3 approaches: MIP, MIP with preoperative ultrasonography, and routine BNE with intraoperative thyroid evaluation. We tested the robustness of the optimal decision with sensitivity analyses. Setting: A tertiary care academic medical center. Main Outcome Measure: Total costs from a provider perspective. Results: Minimally invasive parathyroidectomy without an active search for thyroid abnormalities was determined to have the lowest expected cost ($5275 per patient). Parathyroid surgery with routine preoperative thyroid ultrasonography and further thyroid treatment as indicated had an expected cost of $5910 per patient. Bilateral neck exploration with intraoperative thyroid evaluation and treatment of the thyroid gland had an expected cost of $5916 per patient. Sensitivity analyses confirmed the robustness of the results across a reasonable range of surgical and imaging costs. Conclusions: Minimally invasive parathyroidectomy is not contraindicated on the basis of cost by an inability to screen for synchronous thyroid disease. In addition, ultrasonographic screening of the thyroid glands of patients undergoing MIP is not cost prohibitive and, in fact, is less costly than BNE. Ultrasonography has the added advantage of confirming the location of the offending parathyroid.

UR - http://www.scopus.com/inward/record.url?scp=35348965688&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35348965688&partnerID=8YFLogxK

U2 - 10.1001/archotol.133.10.1013

DO - 10.1001/archotol.133.10.1013

M3 - Article

C2 - 17938325

AN - SCOPUS:35348965688

VL - 133

SP - 1013

EP - 1021

JO - JAMA Otolaryngology - Head and Neck Surgery

JF - JAMA Otolaryngology - Head and Neck Surgery

SN - 2168-6181

IS - 10

ER -